Loading...
ABHI Welcomes MedStride
We are pleased to share that MedStride has joined the Association of British HealthTech Industries (ABHI), marking an important step in our commitment to supporting the MedTech community across the UK and beyond.
MedStride was founded with a clear purpose: to simplify regulatory pathways so MedTech innovators can move forward with confidence. As regulatory expectations under EU MDR and UKCA frameworks continue to evolve, manufacturers face increasing complexity, particularly in high-risk and implantable technologies where clinical and technical evidence must withstand rigorous scrutiny.
Our work focuses on bringing clarity to that complexity.
We support both early-stage innovators and established manufacturers in navigating regulatory strategy, clinical evidence requirements, and technical documentation. By ensuring submissions are clear, structured, and aligned with regulatory expectations from the outset, we help reduce delays, mitigate risk, and enable more efficient routes to market.
Our approach is grounded in direct experience within the regulatory system. Having worked extensively with Notified Bodies and reviewed a wide range of submissions across different device categories, we understand what strong, review-ready documentation looks like and where common pitfalls arise.
Joining ABHI allows us to contribute to a broader ecosystem of health technology organisations committed to advancing safe and effective innovation. It also provides an opportunity to engage more closely with manufacturers, partners, and stakeholders working at the forefront of medical technology.
We look forward to collaborating with the ABHI community and continuing to support MedTech innovators in bringing high-quality, compliant technologies to patients.
To learn more about our work, visit: https://medstride.co.uk/
